Provided by Tiger Trade Technology Pte. Ltd.

Cellectar Biosciences

2.32
+0.01000.43%
Volume:45.19K
Turnover:105.29K
Market Cap:21.93M
PE:-1.05
High:2.45
Open:2.33
Low:2.29
Close:2.31
52wk High:6.52
52wk Low:2.20
Shares:9.45M
Float Shares:9.01M
Volume Ratio:2.16
T/O Rate:0.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2100
EPS(LYR):-8.3544
ROE:-119.57%
ROA:-58.44%
PB:0.73
PE(LYR):-0.28

Loading ...

Mar 18, 2025

Major Issues Report

Form 8-K - Current report
Mar 13, 2025

Major Issues Report

Form 8-K - Current report
Mar 13, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 04, 2025

Correspondence

Form CORRESP - Correspondence
Jan 31, 2025

Major Issues Report

Form 8-K - Current report
Jan 29, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jan 14, 2025

Major Issues Report

Form 8-K - Current report
Dec 11, 2024

Major Issues Report

Form 8-K - Current report
Nov 18, 2024

Major Issues Report

Form 8-K - Current report
Nov 18, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 15, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 01, 2024

Major Issues Report

Form 8-K - Current report
Oct 29, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 29, 2024

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Oct 29, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Aug 23, 2024

Major Issues Report

Form 8-K - Current report
Aug 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 13, 2024

Major Issues Report

Form 8-K - Current report